Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

SGMOQSGMOQ
Showing 8 of 31 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in SANGAMO THERAPEUTICS, INC

As of its Q1 2026 13F, Geode Capital Management held 4,570,862 shares of SGMOQ (Sangamo Therapeutics), worth $1.1M. Geode Capital Management's 13F filings listed SGMOQ from Q4 2018 to Q1 2026, 30 quarterly filings.

Final Value

$0

Final Shares

0

Total Value Change

-$1.9M

Total Shares Change

-2.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$0.05
0
2026-Q1
Increased
4.6M
+18.2%
$1.1M0.0%$0.25
30
2025-Q4
Increased
3.9M
+17.6%
$1.6M0.0%$0.42
30
2025-Q3
Increased
3.3M
+40.9%
$2.2M0.0%$0.67
35
2025-Q2
Increased
2.3M
+2.1%
$1.3M0.0%$0.54
26
2025-Q1
Increased
2.3M
+3.2%
$1.5M0.0%$0.66
26
2024-Q4
Increased
2.2M
+3.4%
$2.3M0.0%$1.02
27
2024-Q3
Increased
2.1M
+14.6%
$1.9M0.0%$0.87
29

Other major holders of SGMOQ: WASATCH ADVISORS LP, STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used